Hilary Baldwin, MD is a board-certified dermatologistand medical director of the Acne Treatment & Research Center in Brooklyn, New York. She is a fellow of the American Academy of Dermatology and a founding board member and secondpresident of the American Acne and Rosacea Society. In addition to numerouspublications in dermatology, Baldwin has served as the principal investigator on many clinical trials, including the phase 3 tretinoin and benzoyl peroxide cream, 0.1%/3% (TWYNEO Cream) trial.